| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.093 | 0.006 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | -0.11 | 0.007 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | 0.077 | 0.007 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.087 | 0.007 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | 0.09 | 0.007 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.007 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | 0.09 | 0.008 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | 0.094 | 0.009 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | 0.089 | 0.01 |